RESUMEN
In the years 2006-2011, 617 Proteus spp. strains isolated mostly from urine and wounds or other clinical sources were collected in Lódz, Poland, to determine the offensive O serotypes frequently occurring among patients. P. mirabilis exhibited the most intensive swarming growth and was dominating species (86.9%), followed by P. genomospecies, P. vulgaris, and P. penneri. Ninety four per cent strains were recognized as S (smooth) forms. Serological studies (involving ELISA-enzyme-linked immunosorbent assay and Western blotting using native and adsorbed rabbit antisera) enabled classification of 80% S isolates into respective Proteus O serogroups among the 83 ones, described so far. The remaining strains seemed to be serologically unique. Despite the observed big serological variety of Proteus spp. isolates, we found the O78 serogroup recently described in Poland as dominating and identified other widespread serotypes: O3, O6, O10, O11, O27, O28, and O30 reported earlier as predominating also in other countries; O77 and O79 detected lately in Poland; O16, O18, O20, and O50. No unique structural feature of the prevalent O serotypes has been indicated. However, the prevalence of some O serogroups indicates that particular serotypes may be in some ways beneficial to the strains producing these kinds of O antigen.
Asunto(s)
Antígenos O/inmunología , Infecciones por Proteus/microbiología , Proteus/inmunología , Humanos , Polonia , Proteus/aislamiento & purificación , Proteus/patogenicidad , Infecciones por Proteus/sangre , Infecciones por Proteus/diagnóstico , Infecciones por Proteus/inmunología , Serogrupo , Serotipificación/métodos , Virulencia/inmunologíaRESUMEN
This study aimed to analyze the proinflammatory cytokine mRNA expression in the urinary tract of BALB/c mice infected with bacterial strains with uropathogenic potential. Groups of four 6-week-old female BALB/c mice were intraurethrally inoculated with 5 × 107 colony-forming units (CFU) of P. mirabilis ATCC29906, EAEC O42, P. mirabilis RTX339, or sterile saline (control group) and then sacrificed at 0, 2, 4, 7, or 10 days post-infection (p.i.). Samples were cultured to determine the CFU/mL in urine or CFU/g in the bladders and kidneys. Cytokine expression (tumor necrosis factor (TNF)-α and interleukin (IL)-1ß, -6, and -8) was evaluated in the target organs using real-time PCR and immunohistochemistry; histology was examined with hematoxylin and eosin staining. The results are presented as the means and standard deviations and were compared using one-way ANOVA, with p < 0.05 indicating significant differences. Bacteriuria was not detected in the infected groups; bacterial colonization occurred in the target organs at all time points, but was higher in mice infected with EAEC O42 or P. mirabilis RTX339 at 7 days p.i. The expression of all cytokine mRNAs was seen, but only the levels of the IL-8 protein increased in situ at 7 days p.i. in the P. mirabilis RTX339 and EAEC O42 groups in both organs. Morphological alterations, observed in all of the infected groups, were more prominent in the EAEC O42 and P. mirabilis RTX339 groups. The findings provide insights into the uropathogenicity and inflammatory cytokine expression in the urinary tract of mice infected with three previously untested bacterial strains.
Asunto(s)
Citocinas/genética , Infecciones por Escherichia coli/inmunología , Inflamación/inmunología , Infecciones por Proteus/inmunología , Infecciones Urinarias/inmunología , Animales , Citocinas/inmunología , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/orina , Femenino , Inflamación/microbiología , Riñón/microbiología , Ratones , Ratones Endogámicos BALB C , Infecciones por Proteus/orina , Proteus mirabilis/patogenicidad , Vejiga Urinaria/microbiología , Sistema Urinario/inmunología , Sistema Urinario/microbiología , Infecciones Urinarias/microbiologíaRESUMEN
Complicated urinary tract infections (UTIs) caused by Proteus mirabilis are among the most common disorders. An effective vaccine could reduce the prevalence of such infections and antibiotic resistance in society. In the present study, the immunogenicity and protective efficacy of different combinations of the MrpH adhesion and flagellin (FliC) of P. mirabilis was evaluated in a prime-boost strategy of vaccination. Applying the FliC as an adjuvant resulted in the stimulation of mixed Th1- and Th2-immune responses against the truncated form of MrpH with a shift toward Th1. Furthermore, flagellin could maintain the persistence of antibody responses for at least 22â¯weeks after the first vaccine dose. It was found that the MrpH, especially in the fusion form, could improve the serum antibody and cellular responses of FliC alone and this suggests the possible adjuvant role of MrpH. The fusion MrpH.FliC and the mixture of FliC with MrpH indicated the highest humoral and cellular responses; this could significantly reduce the load of bacteria in the bladder and kidneys as compared to the control mice. In this study, the adjuvant property of the recombinant flagellin of P. mirabilis was evaluated for the first time in a vaccine candidate against UTI. The flagellin-based vaccines could induce the protective responses through a combination of mucosal and systemic route of administration. Such data indicates that the vaccine combinations of FliC and MrpH from P. mirabilis in fusion and non-fusion forms could be promising candidates for elimination of P. mirabilis in the urinary tract.
Asunto(s)
Adhesinas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Proteínas Fimbrias/inmunología , Infecciones por Proteus/inmunología , Proteus mirabilis/fisiología , Infecciones Urinarias/inmunología , Adhesinas Bacterianas/genética , Adyuvantes Inmunológicos , Animales , Proteínas Bacterianas/inmunología , Células Cultivadas , Vías de Administración de Medicamentos , Femenino , Proteínas Fimbrias/genética , Flagelina/inmunología , Humanos , Inmunización Secundaria , Ratones , Eliminación de Secuencia/genética , VacunaciónAsunto(s)
Linfocitos B/inmunología , Inmunoglobulina A Secretora/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Inmunoterapia Adoptiva/efectos adversos , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Infecciones Urinarias/inmunología , Infecciones Urinarias/microbiología , Antígenos CD19/análisis , Antimetabolitos Antineoplásicos/uso terapéutico , Bacteriuria , Niño , Clofarabina/uso terapéutico , Citarabina/uso terapéutico , Escherichia coli/inmunología , Infecciones por Escherichia coli/inmunología , Femenino , Humanos , Inmunoterapia Adoptiva/métodos , Recuento de Linfocitos , Recurrencia Local de Neoplasia/tratamiento farmacológico , Infecciones por Proteus/inmunología , Proteus mirabilis/inmunologíaRESUMEN
Proteus mirabilis is common cause of urinary tract infections (UTIs) especially in complicated UTIs which are resistant to antibiotic therapy, Consequently, an ideal vaccine is inevitably required. The N-terminal domain of MrpH (Truncated form of MrpH) lies between the most critical antigens of P. mirabilis to consider as vaccine candidate. FliC of Salmonella typhimurium induces several pathways of immunity system, which leads to produce antibody and cytokines. In this study, adjuvant properties of FliC and efficacy of truncated MrpH as important antigen, in tMrpH.FliC were determined in in vitro and in vivo circumstances. Three proteins including: FliC, MrpH and tMrpH.FliC were injected to mice and subsequently sera and supernatant of cell culture were collected to evaluate different immune responses. According to our findings, tMrpH.FliC could stimulate both humoral and cellular immune responses, so that serum IgG, urine IgA, IL.4, IFN-γ and IL.17 were increased significantly in comparison to MrpH and FliC alone, this augmentation was considerable. Results showed significant decrease of bacterial load in all of the challenged groups compared to the control group, although this protective effect was the highest in mice vaccinated with tMrpH.FliC. Our results showed truncated MrpH, without an unwanted domain is an ideal vaccine target and FliC, as adjuvant, increases its immunogenic property. Thus, fusion protein tMrpH.FliC can be considered as promising vaccine against P. mirabilis.
Asunto(s)
Adhesinas Bacterianas/inmunología , Adyuvantes Inmunológicos , Proteínas Fimbrias/inmunología , Flagelina/inmunología , Inmunogenicidad Vacunal/inmunología , Infecciones por Proteus/inmunología , Proteus mirabilis/patogenicidad , Infecciones Urinarias/prevención & control , Adhesinas Bacterianas/genética , Animales , Anticuerpos Antibacterianos/sangre , Formación de Anticuerpos , Clonación Molecular , Citocinas/metabolismo , ADN Bacteriano , Femenino , Proteínas Fimbrias/genética , Flagelina/genética , Fusión Génica , Inmunidad Celular , Inmunidad Humoral , Inmunoglobulina A/orina , Inmunoglobulina G/sangre , Interferón gamma/metabolismo , Interferón gamma/orina , Interleucina-17/metabolismo , Interleucina-4/metabolismo , Riñón/inmunología , Ratones , Ratones Endogámicos BALB C , Simulación del Acoplamiento Molecular , Dominios y Motivos de Interacción de Proteínas , Infecciones por Proteus/microbiología , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Salmonella typhimurium/metabolismo , Vejiga Urinaria/inmunología , Infecciones Urinarias/microbiologíaRESUMEN
Cyclic AMP receptor protein (Crp) is a major transcriptional regulator in bacteria. This study demonstrated that Crp affects numerous virulence-related phenotypes, including colonization of mice, motility, fimbria-mediated adhesion, and glucose stress tolerance in uropathogenic Proteus mirabilis. Diabetic mice were more susceptible to kidney colonization by wild-type strain than nondiabetic mice, in which the crp mutant exhibited increased kidney colonization. Loss of crp or addition of 10% glucose increased the P. mirabilis adhesion to kidney cells. Direct negative regulation of pmpA (which encodes the major subunit of P-like fimbriae) expression by Crp was demonstrated using a reporter assay and DNase I footprinting. Moreover, the pmpA/crp double mutant exhibited reduced kidney adhesion comparable to that of the pmpA mutant, and mouse kidney colonization by the pmpA mutant was significantly attenuated. Hence, the upregulation of P-like fimbriae in the crp mutant substantially enhanced kidney colonization. Moreover, increased survival in macrophages, increased stress tolerance, RpoS upregulation, and flagellum deficiency leading to immune evasion may promote kidney colonization by the crp mutant. This is the first study to elucidate the role of Crp in the virulence of uropathogenic P. mirabilis, underlying mechanisms, and related therapeutic potential.
Asunto(s)
Adhesión Bacteriana , Proteína Receptora de AMP Cíclico/metabolismo , Fimbrias Bacterianas/fisiología , Infecciones por Proteus/metabolismo , Infecciones por Proteus/microbiología , Proteus mirabilis/fisiología , Estrés Fisiológico , Adaptación Biológica , Animales , Sitios de Unión , Línea Celular , Supervivencia Celular , Proteína Receptora de AMP Cíclico/genética , Diabetes Mellitus Experimental , Modelos Animales de Enfermedad , Regulación Bacteriana de la Expresión Génica , Glucosa/metabolismo , Humanos , Macrófagos/inmunología , Macrófagos/metabolismo , Macrófagos/microbiología , Ratones , Mutación , Unión Proteica , Infecciones por Proteus/inmunologíaRESUMEN
BACKGROUND: Proteus mirabilis poses a critical burden on the breeding industry, but no efficient vaccine is available for animals. METHOD: A recombinant Lactococcus lactis expressing the ompA of P. mirabilis was used to develop a vaccine. The mucosal and systemic immune responses of the recombinant vaccine were evaluated in mice after oral immunisation. The inhibition on P. mirabilis colonisation of vaccines was also determined. Moreover, Taishan Pinus massoniana pollen polysaccharides (TPPPS) were used as adjuvants to examine the immunomodulatory effects. RESULTS: The pure recombinant L. lactis vaccine significantly induced the production of specific IgA and IgG, IL-2, IL-4, IFN-γ, and T lymphocyte proliferation, and the immunised mice exhibited significant resistance to P. mirabilis colonisation. Notably, the TPPPS adjuvant vaccines induced higher levels of immune responses than the pure L. lactis. CONCLUSIONS: The L. lactis as a vaccine vehicle combined with TPPPS adjuvant provides a feasible method for preventing P. mirabilis infection.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa/metabolismo , Vacunas Bacterianas/inmunología , Lactococcus lactis/genética , Complicaciones del Embarazo/inmunología , Infecciones por Proteus/inmunología , Proteus mirabilis/metabolismo , Adyuvantes Inmunológicos/genética , Administración Oral , Animales , Proteínas de la Membrana Bacteriana Externa/genética , Bovinos , Estudios de Factibilidad , Femenino , Humanos , Inmunidad Innata , Inmunización , Ratones , Ratones Endogámicos BALB C , Pinus/inmunología , Polen/inmunología , Polisacáridos/genética , Polisacáridos/inmunología , Embarazo , Proteínas Recombinantes/inmunologíaRESUMEN
Introducción: Las infecciones de vías urinarias (IVU) constituyen un problema de salud mundial. El aumento de la resistencia bacteriana a los antimicrobianos limita la administración de antibióticos económicos y de espectro limitado, lo que afecta el costo y el acceso a la atención. El objetivo de este trabajo es determinar la sensibilidad, resistencia y germen causal en urocultivos realizados en pacientes con infección clínica de vías urinarias. Métodos: Estudio transversal. Se analizaron urocultivos de pacientes con infección clínica de vías urinarias, cada urocultivo correspondió a un paciente. Las variables fueron edad, género, microorganismo causal, resistencia y sensibilidad a los antimicrobianos. Se realizó en la Unidad de Medicina Familiar No. 222 del Instituto Mexicano del Seguro Social en Toluca Estado de México. Se evaluaron urocultivos con más de 100000 Unidades formadoras de colonias. Se realizó mediciones descriptivas, frecuencias y porcentajes en el programa SPSS v. 17 para Windows. Resultados: se incluyeron urocultivos de pacientes con infección clínica de vías urinarias. La edad promedio de los pacientes fue de 50.09 ± 19.43 años, con predominio del género femenino (211 pacientes). Los agentes causales más frecuentes fueron: Escherichia Coli (51.91%), Proteus mirabilis (14.70%) y Staphylococcus (11.11 %). Los antibióticos con mayor sensibilidad fueron: imipenem, cefotetan y meropenem (34%). Los antimicrobianos con mayor resistencia fueron: ampicilina (24%), ciprofloxacino (22%) y ampicilina con sulbactam (20%). Conclusiones: los microorganismos más frecuentemente fueron: Escherichia coli y Proteus; y los antimicrobianos a los que mostraron más resistencia bacteriana fueron: ampicilina y quinolonas.
Introduction: Urinary tract infections (UTIs) are a global health problem. Increased bacterial resistance to antimicrobials limits the administration of low-spectrum antibiotics, which affect cost and access to care. The objective of this work is to determine the sensitivity, resistance and causal germ in urine cultures in patients with clinical urinary tract infection Methods: Transversal study. Urine cultures of patients with clinical urinary tract infection were analyzed, each urine culture corresponded to one patient. The variables were age, gender, causal microorganism, resistance and sensitivity to antimicrobials. It was performed at the Family Medicine Unit No. 222 of the Mexican Institute of Social Security in Toluca State of Mexico. Urocultures were evaluated with more than 100,000 colony forming units. Measurements were made frequencies and percentages in the SPSS program version 17 for Windows. Results: there were included 558 urine cultures; the average age was 50.09 ± 19.43 years, female predominance (211 patients). The most common causative microorganisms were Escherichia coli (51.91%), Proteus mirabilis (14.70%) and Staphylococcus (11.11%). Most sensitive antibiotics were: imipenem, meropenem and cefotetan (34%). Most resistance antimicrobial were: ampicillin (24%), ciprofloxacin (22%) and ampicillin with sulbactam (20%). Conclusions: Escherichia coli and Proteus were the most commonly isolated microorganisms; Ampicillin and quinolones showed more bacterial resistence.
Asunto(s)
Humanos , Adulto , Persona de Mediana Edad , Anciano , Infecciones por Proteus/inmunología , Infecciones Bacterianas/terapia , Infecciones Urinarias/terapia , Estudios Transversales , Escherichia coli Uropatógena/inmunología , Toma de Muestras de Orina , Antiinfecciosos/uso terapéutico , Antibacterianos/uso terapéuticoRESUMEN
Urinary tract infections (UTIs) and catheter-associated UTIs (CAUTIs) are the principal hospital-acquired infections. Proteus mirabilis is characterized by several virulence factors able to promote adhesion and biofilm formation and ameliorate the colonization of urinary tract and the formation of crystalline biofilms on the abiotic surface of the urinary catheters. Since, to date, the role of P. mirabilis in the etiopathogenesis of different types of urinary tract infections is not well established, in this study we sought to characterize two different clinically isolated strains of P. mirabilis (PM1 and PM2) with distinctive phenotypes and analyzed various virulence factors possibly implicated in the ability to induce UTIs and CAUTIs. In particular, we analyzed motility, biofilm formation both on abiotic and biotic surfaces of PM1 and PM2 and paralleled these parameters with the ability to induce an inflammatory response in an epithelial cell model. Results showed that PM1 displayed major motility and a capacity to form biofilm and was associated with an anti-inflammatory response of host cells. Conversely, PM2 exhibited lack motility and a had slower organization in biofilm but promoted an increase of proinflammatory cytokine expression in infected epithelial cells. Our study provides data useful to start uncovering the pathologic basis of P. mirabilis-associated urinary infections. The evidence of different virulence factors expressed by PM1 and PM2 highlights the possibility to use precise and personalized therapies targeting specific virulence pathways.
Asunto(s)
Biopelículas/crecimiento & desarrollo , Inmunomodulación , Infecciones por Proteus/inmunología , Infecciones por Proteus/microbiología , Proteus mirabilis/fisiología , Regulación Bacteriana de la Expresión Génica , Genes Bacterianos , Interacciones Huésped-Patógeno/inmunología , Humanos , Fenotipo , Proteus mirabilis/clasificación , Proteus mirabilis/aislamiento & purificación , Infecciones Urinarias/inmunología , Infecciones Urinarias/microbiología , Factores de VirulenciaRESUMEN
Urinary tract infections (UTIs) pose a threat especially to women, the individuals with weakened immunity or with abnormalities in the urinary tract as well as to hospitalized and catheterized patients. The bacteria from the genus Proteus, especially P. mirabilis, are important UTI pathogenic factors. They frequently cause chronic, recurrent or severely complicated infections, resulting in the urinary stones production due to urease and other virulence factors. The ability to survive inside the stones and the increasing antibiotic resistance make it difficult to eradicate the bacteria from the urinary tract. A good solution to the problem may be the vaccination which obtained the interest from the surveyed persons, in spite of the antivaccination attitudes visible also in Poland. Currently, there are four vaccines available, composed of killed cells of different uropathogens, including Proteus spp. They are administrated intranassaly or vaginally and require many booster doses. They decrease the probability of reinfection in patients suffering from recurrent UTIs but the mechanisms of the immune response have not been exactly defined. Promising results were obtained in the studies on a mice model concerning the subunit, conjugated vaccines in which various P. mirabilis surface antigens (with the exception of flagellin) were successfully employed. Hitherto, the best results were obtained by the intranasal vaccinations, using MR/P fimbriae antigens with MPL or cholera toxin adjuvants and the antigens expressed in Lactococcus lactis or Salmonella Typhimurium. It led to an increase in the levels of the specific serum and mucosal antibodies resulting in the protection against P. mirabilis UTIs.
Asunto(s)
Vacunas Bacterianas/uso terapéutico , Infecciones por Proteus/prevención & control , Proteus mirabilis , Infecciones Urinarias/prevención & control , Adyuvantes Inmunológicos , Femenino , Humanos , Masculino , Polonia , Infecciones por Proteus/inmunología , Infecciones Urinarias/microbiologíaRESUMEN
The microbiota stimulates inflammation, but the signaling pathways and the members of the microbiota involved remain poorly understood. We found that the microbiota induces interleukin-1ß (IL-1ß) release upon intestinal injury and that this is mediated via the NLRP3 inflammasome. Enterobacteriaceae and in particular the pathobiont Proteus mirabilis, induced robust IL-1ß release that was comparable to that induced by the pathogen Salmonella. Upon epithelial injury, production of IL-1ß in the intestine was largely mediated by intestinal Ly6C(high) monocytes, required chemokine receptor CCR2 and was abolished by deletion of IL-1ß in CCR2(+) blood monocytes. Furthermore, colonization with P. mirabilis promoted intestinal inflammation upon intestinal injury via the production of hemolysin, which required NLRP3 and IL-1 receptor signaling in vivo. Thus, upon intestinal injury, selective members of the microbiota stimulate newly recruited monocytes to induce NLRP3-dependent IL-1ß release, which promotes inflammation in the intestine.
Asunto(s)
Proteínas Portadoras/inmunología , Inflamasomas/inmunología , Interleucina-1beta/inmunología , Microbiota/inmunología , Monocitos/inmunología , Simbiosis/inmunología , Animales , Antígenos Ly/genética , Antígenos Ly/inmunología , Proteínas Portadoras/genética , Regulación de la Expresión Génica , Proteínas Hemolisinas/genética , Proteínas Hemolisinas/inmunología , Inflamasomas/genética , Inflamación/genética , Inflamación/inmunología , Inflamación/microbiología , Inflamación/patología , Interleucina-1beta/genética , Intestinos/inmunología , Intestinos/lesiones , Intestinos/microbiología , Macrófagos/inmunología , Macrófagos/microbiología , Macrófagos/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Monocitos/microbiología , Monocitos/patología , Proteína con Dominio Pirina 3 de la Familia NLR , Infecciones por Proteus/genética , Infecciones por Proteus/inmunología , Infecciones por Proteus/microbiología , Infecciones por Proteus/patología , Proteus mirabilis/inmunología , Receptores CCR2/genética , Receptores CCR2/inmunología , Salmonella/inmunología , Infecciones por Salmonella/genética , Infecciones por Salmonella/inmunología , Infecciones por Salmonella/microbiología , Infecciones por Salmonella/patología , Transducción de SeñalRESUMEN
Proteus mirabilis is a common human pathogen causing recurrent or persistent urinary tract infections (UTIs). The underlying mechanisms for P. mirabilis to establish UTIs are not fully elucidated. In this study, we showed that loss of the sigma factor E (RpoE), mediating extracytoplasmic stress responses, decreased fimbria expression, survival in macrophages, cell invasion, and colonization in mice but increased the interleukin-8 (IL-8) expression of urothelial cells and swarming motility. This is the first study to demonstrate that RpoE modulated expression of MR/P fimbriae by regulating mrpI, a gene encoding a recombinase controlling the orientation of MR/P fimbria promoter. By real-time reverse transcription-PCR, we found that the IL-8 mRNA amount of urothelial cells was induced significantly by lipopolysaccharides extracted from rpoE mutant but not from the wild type. These RpoE-associated virulence factors should be coordinately expressed to enhance the fitness of P. mirabilis in the host, including the avoidance of immune attacks. Accordingly, rpoE mutant-infected mice displayed more immune cell infiltration in bladders and kidneys during early stages of infection, and the rpoE mutant had a dramatically impaired ability of colonization. Moreover, it is noteworthy that urea (the major component in urine) and polymyxin B (a cationic antimicrobial peptide) can induce expression of rpoE by the reporter assay, suggesting that RpoE might be activated in the urinary tract. Altogether, our results indicate that RpoE is important in sensing environmental cues of the urinary tract and subsequently triggering the expression of virulence factors, which are associated with the fitness of P. mirabilis, to build up a UTI.
Asunto(s)
Células Epiteliales/microbiología , Regulación Bacteriana de la Expresión Génica , Infecciones por Proteus/microbiología , Proteus mirabilis/genética , Factor sigma/genética , Infecciones Urinarias/microbiología , Animales , Células Epiteliales/efectos de los fármacos , Células Epiteliales/patología , Femenino , Fimbrias Bacterianas/genética , Fimbrias Bacterianas/metabolismo , Humanos , Interleucina-8/biosíntesis , Interleucina-8/metabolismo , Lipopolisacáridos/farmacología , Ratones , Ratones Endogámicos C57BL , Mutación , Polimixina B/farmacología , Regiones Promotoras Genéticas/efectos de los fármacos , Infecciones por Proteus/inmunología , Infecciones por Proteus/patología , Proteus mirabilis/efectos de los fármacos , Proteus mirabilis/inmunología , Proteus mirabilis/patogenicidad , Recombinasas/genética , Recombinasas/metabolismo , Factor sigma/deficiencia , Factor sigma/metabolismo , Urea/farmacología , Infecciones Urinarias/inmunología , Infecciones Urinarias/patología , Urotelio/efectos de los fármacos , Urotelio/microbiología , Urotelio/patología , VirulenciaRESUMEN
Proteus mirabilis (P. mirabilis) is a zoonotic pathogen that has recently presented a rising infection rate in the poultry industry. To develop an effective vaccine to protect chickens against P. mirabilis infection, OmpA, one of the major outer membrane proteins of P. mirabilis, was expressed in Pichia pastoris. The concentration of the expressed recombinant OmpA protein reached 8.0µg/mL after induction for 96h with 1.0% methanol in the culture. In addition, OmpA protein was confirmed by SDS-PAGE and Western blot analysis using the antibody against Escherichia coli-expressed OmpA protein. Taishan Pinus massoniana pollen polysaccharide, a known plant-derived adjuvant, was mixed into the recombinant OmpA protein to prepare the OmpA subunit vaccine. We then subcutaneously inoculated this vaccine into chickens to examine the immunoprotective effects. ELISA analysis indicated that an excellent antibody response against OmpA was elicited in the vaccinated chickens. Moreover, a high protection rate of 80.0% was observed in the vaccinated group, which was subsequently challenged with P. mirabilis. The results suggest that the eukaryotic P. mirabilis OmpA was an ideal candidate protein for developing an effective subunit vaccine against P. mirabilis infection.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa/inmunología , Vacunas Bacterianas/inmunología , Proteínas Recombinantes/inmunología , Vacunas de Subunidad/inmunología , Animales , Anticuerpos Antibacterianos/sangre , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas de la Membrana Bacteriana Externa/aislamiento & purificación , Proteínas de la Membrana Bacteriana Externa/metabolismo , Vacunas Bacterianas/genética , Vacunas Bacterianas/metabolismo , Pollos , Pichia/genética , Pichia/metabolismo , Infecciones por Proteus/inmunología , Infecciones por Proteus/microbiología , Infecciones por Proteus/prevención & control , Proteus mirabilis/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Vacunas de Subunidad/genética , Vacunas de Subunidad/metabolismoRESUMEN
This study was conducted to evaluate the effects of Taishan Robinia pseudoacacia polysaccharide (TRPPS) on immune responses of chickens immunized with Proteus mirabilis outer membrane protein A (OmpA) recombinant protein vaccine. OmpA was expressed in Pichia pastoris and mixed with TRPPS. 360 chickens were randomly divided into six groups. Groups I to IV were treated with OmpA which contained TRPPS of three different dosages, Freund's adjuvant, respectively. Groups V and VI were treated with pure OmpA and physiological saline, respectively. The data showed that the antibody titers against OmpA, the concentration of IL-2, CD4 +, and CD8 +, T lymphocyte proliferation rate in Group II were significantly higher (P < 0.05) than those in the other groups, little difference in SIgA content was observed among groups I to VI. These results indicated that TRPPS strengthened humoral and cellular immune responses against recombinant OmpA vaccine. Moreover, 200 mg/mL TRPPS showed significance (P < 0.05) compared with Freund's adjuvant. Therefore, TRPPS can be developed into an adjuvant for recombinant subunit vaccine.
Asunto(s)
Proteínas de la Membrana Bacteriana Externa/metabolismo , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD8-positivos/inmunología , Pollos/inmunología , Pichia/genética , Polisacáridos/inmunología , Infecciones por Proteus/inmunología , Proteus mirabilis/inmunología , Robinia/inmunología , Vacunas Sintéticas , Adyuvantes Inmunológicos , Animales , Proteínas de la Membrana Bacteriana Externa/genética , Proliferación Celular , Células Cultivadas , China , Femenino , Inmunización , Inmunoglobulina A/sangre , Interleucina-2/sangre , Infecciones por Proteus/prevención & control , Proteus mirabilis/genéticaRESUMEN
Proteus mirabilis expresses several virulence factors including MR/P fimbriae and flagella. Bacterial flagellin has frequently shown interesting adjuvant and protective properties in vaccine formulations. However, native P. mirabilis flagellin has not been analyzed so far. Native P. mirabilis flagellin was evaluated as a protective antigen and as an adjuvant in co-immunizations with MrpA (structural subunit of MR/P fimbriae) using an ascending UTI model in the mouse. Four groups of mice were intranasally treated with either MrpA, native flagellin, both proteins and PBS. Urine and blood samples were collected before and after immunization for specific antibodies determination. Cytokine production was assessed in immunized mice splenocytes cultures. Mice were challenged with P. mirabilis, and bacteria quantified in kidneys and bladders. MrpA immunization induced serum and urine specific anti-MrpA antibodies while MrpA coadministered with native flagellin did not. None of the animals developed significant anti-flagellin antibodies. Only MrpA-immunized mice showed a significant decrease of P. mirabilis in bladders and kidneys. Instead, infection levels in MrpA-flagellin or flagellin-treated mice showed no significant differences with the control group. IL-10 was significantly induced in splenocytes of mice that received native flagellin or MrpA-flagellin. Native P. mirabilis flagellin did not protect mice against an ascending UTI. Moreover, it showed an immunomodulatory effect, neutralizing the protective role of MrpA. P. mirabilis flagellin exhibits particular immunological properties compared to other bacterial flagellins.
Asunto(s)
Antígenos Bacterianos/inmunología , Proteínas Bacterianas/inmunología , Vacunas Bacterianas/inmunología , Flagelina/inmunología , Infecciones por Proteus/prevención & control , Proteus mirabilis/inmunología , Infecciones Urinarias/prevención & control , Adyuvantes Inmunológicos/administración & dosificación , Animales , Anticuerpos Antibacterianos/sangre , Anticuerpos Antibacterianos/orina , Antígenos Bacterianos/administración & dosificación , Proteínas Bacterianas/administración & dosificación , Vacunas Bacterianas/administración & dosificación , Modelos Animales de Enfermedad , Antagonismo de Drogas , Flagelina/administración & dosificación , Interleucina-10/biosíntesis , Riñón/microbiología , Leucocitos Mononucleares/inmunología , Ratones , Infecciones por Proteus/inmunología , Proteus mirabilis/crecimiento & desarrollo , Vejiga Urinaria/microbiología , Infecciones Urinarias/inmunologíaAsunto(s)
Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/microbiología , Caenorhabditis elegans/fisiología , Dieta/métodos , Infecciones por Escherichia coli/inmunología , Glucosa/metabolismo , MAP Quinasa Quinasa 4/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Infecciones por Proteus/inmunología , Proteus mirabilis/inmunología , Transducción de Señal , Infecciones Estafilocócicas/inmunología , AnimalesRESUMEN
Caenorhabditis elegans innate immunity requires a conserved mitogen activated protein kinase (MAPK) pathway that regulates the basal and pathogen-induced expression of immune effectors. Being in the group of opportunistic pathogens, Proteus spp. cause large number of nosocomial infections. Since, Proteus spp. do not cause death in wild type C. elegans, to understand the role and contribution of MAP Kinase pathway, the mutants (sek-1 and pmk-1) of this pathway were employed. Physiological experiments revealed that the Proteus spp. were able to kill MAP Kinase pathway mutant's C. elegans significantly. To understand the involvement of innate immune pathways specific players at the mRNA level, the regulation of few candidate antimicrobial genes were kinetically investigated during Proteus spp. infections. Real-time PCR analysis indicated a regulation of few candidate immune regulatory genes (F08G5.6, lys-7, nlp-29, ATF-7 and daf-16) during the course of Proteus spp. infections. In addition, the lipopolysaccharides (LPS) isolated from Proteus mirabilis upon exposure to mutant C. elegans showed modifications at their functional regions suggesting that the pathogen modifies its internal machinery according to the specific host for effective pathogenesis.
Asunto(s)
Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/microbiología , MAP Quinasa Quinasa 4/metabolismo , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Infecciones por Proteus/inmunología , Proteus mirabilis/inmunología , Transducción de Señal , Animales , Caenorhabditis elegans/inmunología , Proteínas de Caenorhabditis elegans/genética , Perfilación de la Expresión Génica , Técnicas de Inactivación de Genes , Inmunidad Innata , MAP Quinasa Quinasa 4/genética , Proteínas Quinasas Activadas por Mitógenos/genética , Infecciones Oportunistas/inmunología , Análisis de SupervivenciaRESUMEN
Three adjuvants, namely, Taishan Pinus massoniana pollen polysaccharide (TPPPS), white mineral oil (WO) and propolis (PP), were added to the outer membrane protein (OMP) of Proteus mirabilis (P. mirabilis) and their effects were compared. Three hundred 1-day-old chicks were randomly divided into five groups (I-V), with 60 chicks per group, and injected subcutaneously with WO-OMP vaccine (I), PP-OMP vaccine (II), TPPPS-OMP vaccine (III), OMP-only vaccine (IV) and physiological saline (V) at 3, 7 and 12 days old. On days 3, 7, 14, 21, 28, 35, 42 and 49 after the first vaccination, the antibody titers, interleukin-2 levels (IL-2) and T-lymphocyte proliferation rates in the peripheral blood as well as the secreting-type IgA levels (SIgA) in the duodenum were measured. On day 7 after the third vaccination, the chicks were challenged with P. mirabilis strain Q1 and the protective effects of each group were observed. The highest protective rate was observed in group III. Moreover, the antibody titers as well as IL-2, SIgA and T-lymphocyte proliferation rates in this group significantly increased and were significantly higher than those in the other groups at most time points. The results indicate that TPPPS could significantly enhance the effects of the subunit vaccine of P. mirabilis; induced stronger humoral, cellular and mucosal immunity as compared with WO and PP; and should be developed as a vaccine adjuvant.
Asunto(s)
Vacunas Bacterianas/inmunología , Pollos/inmunología , Pollos/microbiología , Polisacáridos/farmacología , Proteus mirabilis/efectos de los fármacos , Proteus mirabilis/inmunología , Vacunas de Subunidad/inmunología , Adyuvantes Inmunológicos/farmacología , Animales , Anticuerpos Antibacterianos/sangre , Proliferación Celular , Pollos/sangre , Duodeno/efectos de los fármacos , Duodeno/metabolismo , Duodeno/microbiología , Duodeno/patología , Electroforesis en Gel de Poliacrilamida , Inmunoglobulina A Secretora/metabolismo , Interleucina-2/sangre , Masculino , Proteínas de la Membrana/inmunología , Infecciones por Proteus/inmunología , Infecciones por Proteus/microbiología , Infecciones por Proteus/prevención & control , Linfocitos T/citología , Linfocitos T/inmunología , VacunaciónRESUMEN
Effects of Proteus vulgaris OX19 on the spleen cells of rabbits were investigated. Control group (n=5) and Proteus treated group (n=5) of New Zealand male rabbits were used in this study. Bacteria were injected to the rabbits in five days periods with increasing dosages for one month. Thin sections were examined by transmission electron microscope (Jeol 100CXII). Ultrastructural changes were defined in spleen tissue cells due to the antigenic stimulation of bacteria. Spleen cells observed in control group were in normal structure and cells were in close contact with each other. However, spleen cells of Proteus treated group displayed structural changes with regard to the control group in electron microscopic examinations. Chemotaxis of macrophages, forming of pseudopodia and presence of phagocytic vacuoles were observed. Lymphocytes, the major cells of spleen revealed mitotic activity. In addition, chromatin condensation in nucleus and dilatations in perinuclear space were significant. Interactions of lymphocytes and macrophages were noteworthy.
Asunto(s)
Linfocitos/inmunología , Macrófagos/inmunología , Infecciones por Proteus/inmunología , Infecciones por Proteus/patología , Proteus vulgaris , Bazo/ultraestructura , Animales , Movimiento Celular , Masculino , Microscopía Electrónica de Transmisión , Conejos/inmunología , Conejos/microbiología , Bazo/inmunologíaRESUMEN
The aim of this work was to serotype Proteus mirabilis urinary tract infection (UTI) strains based on chemically defined O-antigens with the use of two clinical collections from Sweden and Poland consisting of 99 and 24 UTI strains, respectively. A simple two-step serotyping scheme was proposed using enzyme immunoassay with heat-stable surface antigens of Proteus cells and immunoblotting with isolated lipopolysaccharides (LPSs). Using polyclonal anti-P. mirabilis rabbit antisera, 50 Swedish and 8 Polish strains were classified into serogroups O10, O38, O36, O30, O17, O23, O9, O40, O49, O27, O5, O13, O24, O14, and O33. From the Swedish strains, 10 belonged to serogroup O10 and five to each of serogroups O38, O36, and O9. Therefore, none of the O-serogroups was predominant. The majority of the serotyped clinical strains possess acidic O-antigens containing uronic acids and various acidic non-carbohydrate substituents. In immunoblotting, antisera cross-reacted with both O-antigen and core of LPSs. The core region of 19 LPSs bound a single serum, and that of 12 LPSs bound more than two sera. Following bioinformatic analysis of the available sequences, a molecular approach to the prediction of Proteus core oligosaccharide structures was proposed. The identification of the core type of P. mirabilis R110, derived from a serogroup O3 wild strain, using restriction fragments length polymorphism analysis of galacturonic acid transferase is shown as an example. In summary, the most frequent O-serogroups among P. mirabilis UTI stains were identified. The diversity of serological reactions of LPSs is useful for serotyping of P. mirabilis clinical isolates. A possible role of the acidic components of O-antigens in UTI is discussed.